Evidence map›Paper›PMID 41268824›Full record

ArticleEuropean journal of anaesthesiology2026

Adoption of a novel biomarker-guided quality improvement treatment bundle for patients with subclinical acute kidney injury after cardiac surgery: An implementation study.

Benjamin Milne, Sinead Helyar, Carol Pellowe, Marlies Ostermann, Nicholas Lees, Jackie Donovan, Mandeep Sekhon, Gudrun Kunst

Abstract readMulticenter Study
In one paragraph

Article in European journal of anaesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benjamin MilneFrom the The Department of Anaesthesia, King's College Hospital NHS Foundation Trust, London, UK (BM, GK), the Department of Critical Care, King's College Hospital NHS Foundation Trust, London, UK (BM), NIHR Academic Clinical Fellow, King's College London, London, UK (BM), ACET Research Team, King's College Hospital NHS Foundation Trust, London, UK (SH), the Royal College of Anaesthetists Lay Committee (CP), the Department of Critical Care, Guy's & St Thomas' NHS Foundation Trust, London, UK (MO), the Department of Critical Care, Royal Brompton & Harefield Hospitals, Guy's & St Thomas' NHS Foundation Trust, London, UK (NL), Clinical Biochemistry, Royal Brompton & Harefield Hospitals, Guy's & St Thomas' NHS Foundation Trust, London, UK (JD), Population Health Research Institute, School of Health and Medical Sciences, City St George's, University of London, London, UK (MS), the School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, UK (GK).ORCID 0000-0002-1804-6125
Sinead Helyar
Carol Pellowe
Marlies Ostermann
Nicholas Lees
Jackie Donovan
Mandeep Sekhon
Gudrun Kunst

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence-based peri-operative practices can deliver improved patient outcomes, but their benefits may be limited by obstacles to implementation into routine practice. A multicentre randomised controlled trial demonstrated a reduction in the incidence of moderate-severe acute kidney injury after cardiac surgery using a biomarker-guided renal care bundle, however these measures are not a routine part of clinical practice.

objectiveWe set out to assess the key implementation domains of acceptability, feasibility and appropriateness of this technology-intervention bundle in the cardiac intensive care unit.

designFollowing introduction of the biomarker-guided renal care bundle, the implementation process was assessed using comprehensive and novel implementation science metrics: Weiner's adoption metrics and Sekhon's theoretical framework of acceptability.

settingTwo tertiary cardiac surgical centres in London, UK, between July 2021 and February 2022.

participantsOne hundred and seventy-six adult patients underwent urinary biomarker assessment 2 h after arrival on the cardiac intensive care unit and 49 respondents, including medical and surgical consultants and nursing staff, completed our implementation survey.

interventionsPatients with a raised biomarker level ([TIMP-2] × [IGFBP7] > 0.3 (ng ml -1 ) 2 1000 -1 ) received a renal care bundle. The clinician respondents underwent a survey designed to provide implementation metrics.

main outcome measureThe primary outcome was the assessment of implementation using Weiner's adoption metrics and Sekhon's theoretical framework of acceptability.

results34.7% ( n  = 61) of patients had a raised biomarker level indicating a requirement for the renal care bundle, with a mean delivery of 4.4 (out of 6) bundle items. Concerning Weiner's adoption metrics, the median scores for acceptability, appropriateness and feasibility were all 4 (out of a possible 5) indicating a high degree of positivity towards the intervention. Similarly, all domains of Sekhon's theoretical framework of acceptability scored a median of 4 (out of 5). The highest scoring domain was Perceived Effectiveness (mean 4.0), whilst the lowest were Burden (mean 3.4) and Opportunity Costs (mean 3.4).

conclusionsThis implementation science study demonstrates that this biomarker-guided renal care bundle is deliverable after cardiac surgery, outside of a research setting. Our findings show that the intervention is acceptable, feasible and appropriate, which is strongly supported by its 'perceived effectiveness'. We have also demonstrated the more negative aspects to be addressed to improve concordance in other settings.

Indexed as

Acute Kidney InjuryCardiac Surgical ProceduresPatient Care BundlesPostoperative ComplicationsQuality ImprovementAgedBiomarkersFeasibility StudiesFemaleHumansImplementation ScienceMaleMiddle AgedTissue Inhibitor of Metalloproteinase-2BiomarkersTissue Inhibitor of Metalloproteinase-2

Identifiers

PMID41268824
PMCPMC13048310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.